1972
DOI: 10.1002/j.1552-4604.1972.tb00159.x
|View full text |Cite
|
Sign up to set email alerts
|

Sulfonamide Vasculitis1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1974
1974
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…There are also indirect effects, based on immunological reactions, which appear with a variable delay. There are several other examples, where different types of mechanisms cause neuropathy: immune checkpoint inhibitors (ICI), where an autoimmune mechanism is activated, sulfonamides that rarely induce vasculitis-causing neuropathy [ 28 ], aerosols that can induce Guillain–Barrè syndrome (GBS) in swine abattoir workers [ 29 ] as well as the Spanish toxic oil syndrome, probably causing vasculitis [ 30 ], or the toxic gold treatments in rheumatology [ 31 ].…”
Section: Clinical Features Of Tnsmentioning
confidence: 99%
“…There are also indirect effects, based on immunological reactions, which appear with a variable delay. There are several other examples, where different types of mechanisms cause neuropathy: immune checkpoint inhibitors (ICI), where an autoimmune mechanism is activated, sulfonamides that rarely induce vasculitis-causing neuropathy [ 28 ], aerosols that can induce Guillain–Barrè syndrome (GBS) in swine abattoir workers [ 29 ] as well as the Spanish toxic oil syndrome, probably causing vasculitis [ 30 ], or the toxic gold treatments in rheumatology [ 31 ].…”
Section: Clinical Features Of Tnsmentioning
confidence: 99%
“…A review of hypersensitivity reaotis to sulphonamides showed that increasing dosage led to a greater frequency of sensitization reactions. It was concluded that the sensiting dose may constitute the trigger which sets the disease process in motion in the susceptible patient (Lehr, 1972).…”
Section: Discussionmentioning
confidence: 99%